PARTNER THERAPEUTICS

Issues lobbied

• HCRHealth Issues
  Issues related to rad/nuc preparedness and response; Pandemic All-Hazards Preparedness and Response
• BUDBudget/Appropriations
  Fiscal Year 2027 HHS appropriations for rad/nuc preparedness and response, specifically within BARDA and the Strategic National Stockpile. Fiscal Year 2027 DOD appropriations for rad/nuc preparedness and response.
• DEFDefense
  Issues related to rad/nuc preparedness and response.

Key facts

Filing UUID

1f63ad9e-91c0-4b53-81d0-b1140e888a45

Filing type

Q1

Filing period

first_quarter

Filing year

2026

Posted

2026-05-04T22:07:05-04:00

Registrant (lobbyist)

SL STRATEGIES, LLC

Client

PARTNER THERAPEUTICS

Client location

MA / US

Client description

biotechnology company

Income reported

$45,000

Expenses reported

—